Validate the Dosimetric Parameters That Correlate With Acute Hematologic Toxicity (HT) in Patients With Rectal Cancer
NCT02630056 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 90
Last updated 2015-12-15
Summary
The purpose of this study is to validate the dosimetric parameters that correlate with acute hematologic toxicity (HT) in patients with rectal cancer treated with neoadjuvant chemoradiotherapy.
Conditions
- Rectal Neoplasm
Sponsors & Collaborators
-
Sixth Affiliated Hospital, Sun Yat-sen University
lead OTHER
Eligibility
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2015-12-31
- Primary Completion
- 2017-08-31
- Completion
- 2017-12-31
More Related Trials
-
Chemoradiotherapy After Surgery Versus Preoperative Chemoradiotherapy for Stage II/III Mid-low Rectal Cancer With or Without High-risk Factors
NCT06566222 ·Status: NOT_YET_RECRUITING
-
A Prospective Phase II Study of Individualized Neoadjuvant Chemoradiotherapy for Rectal Cancer Based on Recurrence Risk
NCT04664504 ·Status: RECRUITING ·Phase: PHASE2
-
Short Course Radiotherapy Combined With Chemotherapy in Stage IV Rectal Cancer With Resectable Liver Metastases
NCT02510378 ·Status: UNKNOWN ·Phase: PHASE2
-
Randomized Controlled Study on Optimize Neoadjuvant Chemoradiotherapy for Locally Advanced Rectal Cancer
NCT02031939 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE3
-
Outcomes of Neoadjuvant Therapy for Rectal Cancer in a Tertiary Asian Institute
NCT05607186 ·Status: COMPLETED
-
Effective Study of Preoperative Short-course Radiotherapy for the Advanced Resectable Rectal Cancer
NCT01437514 ·Status: TERMINATED ·Phase: PHASE2/PHASE3
-
Efficacy and Safety Study of Neoadjuvant in Treating Patients With Resectable Local Recurrent Rectal Cancer
NCT01271192 ·Status: UNKNOWN ·Phase: NA
-
Chemotherapy Combined With High-dose Radiotherapy for Low Rectal Cancer Using MR Guided Linear Accelerator
NCT05338866 ·Status: ENROLLING_BY_INVITATION
-
Total Neoadjuvant Therapy With PD-1 for Locally Advcancer Rectal Cancer
NCT07214142 ·Status: NOT_YET_RECRUITING ·Phase: PHASE2
-
Radical vs Local Excision for Rectal Cancer With Clinically Complete Remission
NCT05964530 ·Status: RECRUITING ·Phase: NA
-
Assessment of Efficacy of Neoadjuvant Therapy in Locally Advanced Rectal Cancer
NCT06314737 ·Status: COMPLETED
-
Neoadjuvant Triplet Chemotherapy Regimen in Patients With Resectable Colorectal Cancer
NCT02688023 ·Status: UNKNOWN ·Phase: PHASE2
-
Effects of Different Radiation Dosimetry for Anorectal Function of Patients With Pelvic Cancer
NCT05832385 ·Status: NOT_YET_RECRUITING
-
Optimization of Preoperative Treatment in Locally Advanced Rectal Cancer
NCT02533271 ·Status: UNKNOWN ·Phase: PHASE3
-
Biomarkers for Predicting Neoadjuvant Chemoradio-resistance for Middle-low Advanced Rectal Cancer
NCT03573791 ·Status: RECRUITING
-
Clinical Effect of Neoadjuvant Hierarchical Treatment Based on Chemotherapy
NCT03071198 ·Status: UNKNOWN ·Phase: NA
-
Clinical Relevance of Major Pathologic Regression for Locally Advanced Rectal Cancer
NCT06879197 ·Status: COMPLETED
-
Short Course Radiotherapy, Unresectable Rectal Cancer, Liver Metastasis
NCT03022734 ·Status: UNKNOWN ·Phase: PHASE2
-
Observational Study on the Patients With Rectal Cancer
NCT02312284 ·Status: COMPLETED
-
Tumor Local Excision +Postoperative Adjuvant Chemoradiotherapy for T1-2N0M0 Low/Ultra-Low Rectal Cancer
NCT06949098 ·Status: RECRUITING ·Phase: PHASE2
-
Neoadjuvant Sequential Therapy in Locally Advanced Mid/Low Rectal Cancer
NCT02022852 ·Status: UNKNOWN ·Phase: PHASE2
-
Radical Concurrent Chemoradiotherapy With DDP/5-FU and PD-1 Antibody for Non-metastatic Rectal Squamous Cell Carcinoma
NCT06364384 ·Status: RECRUITING ·Phase: PHASE2
-
Genetic Profile on Predicting Sensibility of Preoperative Chemoradiotherapy on Locally Advanced Rectal Carcinoma
NCT01930942 ·Status: UNKNOWN ·Phase: PHASE2
-
Preoperative CRT With or Without Induction Chemotherapy for Rectal Cancer With Liver Metastases
NCT01643070 ·Status: COMPLETED ·Phase: PHASE2
-
Organ Preservation Strategy of Total Neoadjuvant Chemoradiotherapy for Low Rectal Carcinoma
NCT05563922 ·Status: RECRUITING ·Phase: PHASE2